HRMY - Harmony Biosciences Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.00
DETAILS
HIGH:
$50.00
LOW:
$31.00
MEDIAN:
$45.50
CONSENSUS:
$43.00
UPSIDE:
42.62%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 251,506 | $7.0M | 0.0% | +22,992 | INCREASED |
| Cooperman | 101,427 | $2.8M | 0.0% | -12,883 | DECREASED |
| Greenblatt | 64,184 | $1.8M | 0.0% | +32,411 | INCREASED |
| Wood | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-14 | Graf R. Mark | director | A-Award | 21,872 | $30.76 | $673K |
| 2026-04-14 | Reicin Glenn | ? | -- | -- | -- | |
| 2026-05-14 | Szyper Linda M | director | A-Award | 21,872 | $30.76 | $673K |
| 2026-05-14 | Philip Ron M | director | A-Award | 21,872 | $30.76 | $673K |
| 2026-05-14 | Sabater Juan A. | director | A-Award | 21,872 | $30.76 | $673K |
| 2026-05-14 | Sender Gary | director | A-Award | 21,872 | $30.76 | $673K |
| 2026-05-01 | Budur Kumar | officer: CHIEF MEDICAL OFFICER | M-Exempt | 18,750 | -- | -- |
| 2026-05-01 | Budur Kumar | officer: CHIEF MEDICAL OFFICER | F-InKind | 8,882 | $31.83 | $283K |
| 2026-04-14 | Reicin Glenn | officer: CHIEF FINANCIAL OFFICER | A-Award | 164,309 | $29.29 | $4.8M |
| 2026-05-14 | Germano Geno J | director | A-Award | 21,231 | $30.76 | $653K |
| 2026-05-14 | Germano Geno J | ? | -- | -- | -- | |
| 2026-04-07 | Zaeske Adam H. | officer: CHIEF COMMERCIAL OFFICER | M-Exempt | 7,500 | -- | -- |
| 2026-04-07 | Zaeske Adam H. | officer: CHIEF COMMERCIAL OFFICER | F-InKind | 3,173 | $27.62 | $88K |
| 2026-04-02 | Ignelzi Troy A. | director | A-Award | 17,710 | $27.74 | $491K |
| 2026-04-02 | Anastasiou Peter | officer: CHIEF OPERATING OFFICER | A-Award | 212,241 | $27.74 | $5.9M |
| 2026-04-02 | Ignelzi Troy A. | ? | -- | -- | -- | |
| 2026-01-26 | Kapadia Sandip | officer: CHIEF FINANCIAL OFFICER | SELL | 3,746 | $37.15 | $139K |
| 2026-01-24 | Kapadia Sandip | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 3,813 | -- | -- |
| 2026-01-25 | Kapadia Sandip | officer: CHIEF FINANCIAL OFFICER | F-InKind | 2,553 | $36.82 | $94K |
| 2026-01-24 | Kapadia Sandip | officer: CHIEF FINANCIAL OFFICER | F-InKind | 2,239 | $36.82 | $82K |
| 2026-01-22 | Serafin Andrew | officer: CHIEF STRATEGY OFFICER | A-Award | 42,600 | $36.76 | $1.6M |
| 2026-01-22 | Serafin Andrew | officer: CHIEF STRATEGY OFFICER | A-Award | 12,200 | -- | -- |
| 2026-01-25 | Serafin Andrew | officer: CHIEF STRATEGY OFFICER | M-Exempt | 2,600 | -- | -- |
| 2026-01-25 | Serafin Andrew | officer: CHIEF STRATEGY OFFICER | F-InKind | 1,126 | $36.82 | $41K |
| 2026-01-22 | Zaeske Adam H. | officer: CHIEF COMMERCIAL OFFICER | A-Award | 56,900 | $36.76 | $2.1M |